Pancreatic cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
(12 intermediate revisions by 6 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Pancreatic_cancer]] | |||
{{CMG}}; {{AE}} {{Cherry}} | {{CMG}}; {{AE}} {{Cherry}} | ||
==Overview== | ==Overview== | ||
[[Pancreatic cancer]] must be | [[Pancreatic cancer]] must be distinguished from other pancreatobiliary pathologies that cause [[abdominal pain]] and [[jaundice]] such as acute [[Pus|suppurative]] [[cholangitis]], [[Cholecystitis|acute cholecystitis]], [[Gallstone disease|cholelithiasis]], [[chronic pancreatitis]], [[primary biliary cirrhosis]] and [[primary sclerosing cholangitis]]. [[Pancreatic cancer]] must also be differentiated from other [[Pancreas|pancreatic]] [[Pathological|pathologies]] such as [[autoimmune pancreatitis]], [[pancreatic pseudocyst]], and [[neuroendocrine tumors]] of the pancreas. [[Pathological|Pathologies]] of the [[bile duct]] and [[duodenum]] such as [[Choledocholithiasis]], [[Gallstone disease|gallstones]] ([[Gallstone disease|cholelithiasis]]), [[Bile duct cyst|choledochal cysts]], [[Cholangiocarcinoma]], [[Bile duct]] [[Stenosis|strictures]] and [[Ampulla of Vater|ampullary]] cancer should be differentiated from [[pancreatic cancer]] based on [[imaging]] and [[biopsy]] findings. [[Metastasis]] from different sites and [[vascular]] causes such as [[Abdominal aortic aneurysm|abdominal aortic aneurysms]] may also mimic [[pancreatic cancer]]. | ||
==Differentiating Pancreatic Cancer from other Diseases== | ==Differentiating Pancreatic Cancer from other Diseases== | ||
Line 13: | Line 13: | ||
| | | | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! colspan="3" rowspan="3 | ! colspan="3" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Classification of pain in the abdomen based on etiology | ||
! rowspan="3 | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Disease | ||
! colspan="8 | ! colspan="8" style="background:#4479BA; color: #FFFFFF;" align="center" |Clinical manifestations | ||
! colspan="2" rowspan="2 | ! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Diagnosis | ||
! rowspan="3 | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Comments | ||
|- | |- | ||
! colspan="4" rowspan="1 | ! colspan="4" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Symptoms | ||
! colspan="4" rowspan="1 | ! colspan="4" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Signs | ||
|- | |- | ||
! colspan="1" rowspan="1 | ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rigors and chills | |||
! | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal Pain | ||
! | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hypo- | |||
tension | tension | ||
! colspan="1" rowspan="1 | ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Guarding | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rebound Tenderness | |||
! | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Bowel sounds | ||
! colspan="1" rowspan="1 | ! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings | ||
! | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | ||
|- | |- | ||
! rowspan=" | ! rowspan="18" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal causes | ||
! colspan="1" rowspan=" | ! colspan="1" rowspan="17" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Inflammatory causes | ||
! rowspan="8" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pancreato-biliary disorders | ! rowspan="8" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pancreato-biliary disorders | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Acute suppurative cholangitis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | Acute suppurative cholangitis | ||
Line 49: | Line 49: | ||
* Abnormal [[LFT]] | * Abnormal [[LFT]] | ||
* WBC >10,000 | * WBC >10,000 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] dilatation/stents/[[tumor]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Septic shock occurs with features of [[SIRS]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Septic shock]] occurs with features of [[SIRS]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Cholangitis|Acute cholangitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Cholangitis|Acute cholangitis]] | ||
Line 62: | Line 62: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Abnormal [[LFT]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Abnormal [[LFT]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[biliary]] dilatation/stents/tumor | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[biliary]] dilatation/stents/tumor | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Biliary drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + IV antibiotics | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Biliary drainage ([[Endoscopic retrograde cholangiopancreatography|ERCP]]) + [[Intravenous|IV]] [[antibiotics]] | ||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Acute cholecystitis|Acute cholecystitis]] | ||
Line 77: | Line 77: | ||
* [[Hyperbilirubinemia]] | * [[Hyperbilirubinemia]] | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows gallstone and evidence of inflammation | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[gallstone]] and evidence of [[inflammation]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | ||
|- | |- | ||
Line 90: | Line 90: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[amylase]] / [[lipase]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[amylase]] / [[lipase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows evidence of [[inflammation]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows evidence of [[inflammation]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Pain radiation to back | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Pain radiation to back | ||
|- | |- | ||
Line 136: | Line 136: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N to hyperactive for dislodged stone | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N to hyperactive for dislodged stone | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Leukocytosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound shows [[gallstone]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] shows [[gallstone]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Murphy's sign|Murphy’s sign]] | ||
|- | |- | ||
Line 161: | Line 161: | ||
* Involvement of the regional [[Lymph node|lymph nodes]] and adjacent [[Circulatory system|vasculature]] | * Involvement of the regional [[Lymph node|lymph nodes]] and adjacent [[Circulatory system|vasculature]] | ||
* [[Pancreatic duct|Pancreatic ductal]] [[Dilation|dilatation]] | * [[Pancreatic duct|Pancreatic ductal]] [[Dilation|dilatation]] | ||
* [[Pancreas|Pancreatic]] atrophy | * [[Pancreas|Pancreatic]] [[atrophy]] | ||
* [[Obstruction]] of the [[Common bile duct|common bile duct (CBD)]] | * [[Obstruction]] of the [[Common bile duct|common bile duct (CBD)]] | ||
* [[Ultrasound|USG]] shows: | * [[Ultrasound|USG]] shows: | ||
ill defined hypoechoic mass is seen infiltrating into a bright ''pancreatic parenchyma'' | ill defined hypoechoic mass is seen infiltrating into a bright ''[[pancreatic]] parenchyma'' | ||
* [[Endoscopic ultrasound|EUS]]-guided [[Fine needle aspiration|fine needle aspiration biopsy (FNA)]] is the best modality for obtaining a tissue diagnosis. | * [[Endoscopic ultrasound|EUS]]-guided [[Fine needle aspiration|fine needle aspiration biopsy (FNA)]] is the best modality for obtaining a tissue [[diagnosis]]. | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Signs of [[Metastasis|metastatic disease]] include: | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Signs of [[Metastasis|metastatic disease]] include: | ||
* Left [[Supraclavicular lymph nodes|supraclavicular]] [[lymphadenopathy]] ([[Virchow's node]]) | * Left [[Supraclavicular lymph nodes|supraclavicular]] [[lymphadenopathy]] ([[Virchow's node]]) | ||
Line 173: | Line 173: | ||
* Involvement of other [[Lymph node|nodes]] in the [[cervical]] area | * Involvement of other [[Lymph node|nodes]] in the [[cervical]] area | ||
|- | |- | ||
! | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastric]] causes | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal perforation]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Gastrointestinal perforation]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 243: | Line 187: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
! rowspan=" | ! rowspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Intestinal]] causes | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Whipple's disease]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Whipple's disease]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
Line 327: | Line 215: | ||
* [[Arthritis]] | * [[Arthritis]] | ||
* [[Ascites]] | * [[Ascites]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Celiac disease]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Celiac disease]] | ||
Line 362: | Line 224: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive (increased sounds) | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Hyperactive]] (increased sounds) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[IgA]] endomysial antibody | * [[IgA]] endomysial [[antibody]] | ||
* [[IgA]] [[tissue transglutaminase]] antibody | * [[IgA]] [[tissue transglutaminase]] antibody | ||
* [[Anti-gliadin antibodies|Anti-gliadin antibody]] | * [[Anti-gliadin antibodies|Anti-gliadin antibody]] | ||
Line 370: | Line 232: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hepatic causes | ! rowspan="5" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatic]] causes | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis|Viral hepatitis]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis|Viral hepatitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 389: | Line 251: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[RUQ]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in sepsis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[sepsis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 414: | Line 276: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |RUQ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |RUQ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in cirrhotic patients | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in cirrhotic patients | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |may be in cardicmyopathy | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |may be in cardicmyopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |>60% TS<br> >240 μg/L SF <br>Raised LFT <br>Hyperglycemia | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |>60% TS<br> >240 μg/L SF <br>Raised LFT <br>[[Hyperglycemia]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Ultrasound shows evidence of cirrhosis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Ultrasound]] shows evidence of [[cirrhosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Extra intestinal findings: | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Extra intestinal findings: | ||
* hyperpigmentation | * [[hyperpigmentation]] | ||
* Diabetes mellitus | * [[Diabetes mellitus]] | ||
* Arthralgia | * [[Arthralgia]] | ||
* Impotence in males | * [[Impotence]] in males | ||
* Cardiomyopathy | * [[Cardiomyopathy]] | ||
* Atherosclerosis | * [[Atherosclerosis]] | ||
* Hypopituitarism | * [[Hypopituitarism]] | ||
* Hypothyroidism | * [[Hypothyroidism]] | ||
* Extrahepatic cancer | * [[Extrahepatic cholangiocarcinoma|Extrahepatic]] cancer | ||
* Prone to specific infections | * Prone to specific [[infections]] | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cirrhosis|Cirrhosis]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cirrhosis|Cirrhosis]] | ||
Line 446: | Line 308: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
! style="padding: 5px 5px; background: #DCDCDC;" align="center" | Peritoneal causes | ! style="padding: 5px 5px; background: #DCDCDC;" align="center" | [[Peritoneal]] causes | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Spontaneous bacterial peritonitis]] | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Spontaneous bacterial peritonitis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Diffuse | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Diffuse | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in cirrhotic patients | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + in [[Cirrhosis|cirrhotic]] patients | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
Line 457: | Line 319: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hypoactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Ascitic fluid [[PMN]]>250 cells/mm<small>³</small> | * [[Ascitic]] [[fluid]] [[PMN]]>250 cells/mm<small>³</small> | ||
* Culture: Positive for single organism | * Culture: Positive for single organism | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound for evaluation of liver cirrhosis | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] for evaluation of liver cirrhosis | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
|- | |- | ||
! colspan="2 | ! colspan="2" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hollow Viscous Obstruction | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Biliary colic]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Biliary colic]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
Line 500: | Line 336: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[bilirubin]] and [[alkaline phosphatase]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Increased [[bilirubin]] and [[alkaline phosphatase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Ultrasound]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Nausea and vomiting|Nausea & vomiting]] | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[Nausea and vomiting|Nausea & vomiting]] | ||
|- | |- | ||
| | |} | ||
| style=" | |} | ||
=== Differentials based on weight loss, nausea, vomiting, diarrhea, fatigue and abdominal pain === | |||
| | Pancreatic carcinoma should be differentiated from other diseases presenting with [[weight loss]], [[nausea]], [[vomiting]], [[diarrhea]], [[fatigue]] and [[abdominal pain]]. The differentials include the following: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Disease | |||
| colspan="13" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestations''' | |||
! colspan="2" rowspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" |Diagnosis | |||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Comments | |||
|- | |- | ||
| colspan="9" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Symptoms''' | |||
! colspan="4" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Signs | |||
|- | |- | ||
| style=" | ! style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal Pain | ||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Fever | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rigors and chills | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Nausea or vomiting | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Jaundice | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Constipation | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Diarrhea | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |GI bleeding | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Hypo- | |||
tension | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Guarding | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Rebound Tenderness | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Bowel sounds | |||
! colspan="1" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" | Lab Findings | |||
! style="background:#4479BA; color: #FFFFFF;" align="center" |Imaging | |||
|- | |- | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Chronic pancreatitis]] | |||
| style="padding: 5px 5px; background: # | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Epigastric]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |CT scan | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Increased [[amylase]] / [[lipase]] | |||
* Increased stool [[fat]] content | |||
* Pancreatic function test | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[CT scan]] | |||
* [[Calcification]] | |||
* [[Pseudocyst]] | |||
* Dilation of main [[pancreatic duct]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Predisposes to pancreatic cancer | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" | | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Pancreatic carcinoma]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Epigastric]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |N | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=" | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
| | * ↑ [[Alkaline phosphatase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | * ↑ [[Bilirubin|serum bilirubin]] | ||
| | * ↑ [[gamma-glutamyl transpeptidase]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |[[ | * ↑ [[CA 19-9]] | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Computed tomography|MDCT]] with [[Positron emission tomography|PET]]/[[Computed tomography|CT]] | |||
* [[MRI]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
[[Skin]] manifestations may include: | |||
* [[Bullous pemphigoid]] | |||
* [[Mucous membrane pemphigoid|Cicatricial pemphigoid]] | |||
* [[Thrombophlebitis|Migratory superficial thrombophlebitis]] (classic [[Trousseau's syndrome]]) | |||
* [[Panniculitis|Pancreatic panniculitis]] | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" | | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Dumping syndrome]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Lower and then diffuse | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>+</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |− | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | − | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" |Hyperactive | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Glucose challenge test | |||
* [[Hydrogen Breath Test|Hydrogen breath test]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Upper [[Gastrointestinal tract|GI]] series | |||
* Gastric emptying study | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Postgastrectomy]] | |||
|} | |} | ||
'''Abbreviations:''' | |||
'''[[RUQ]]'''= Right upper quadrant of the abdomen, '''LUQ'''= Left upper quadrant, '''LLQ'''= Left lower quadrant, '''RLQ'''= Right lower quadrant, '''LFT'''= Liver function test, SIRS= [[Systemic inflammatory response syndrome]], '''[[ERCP]]'''= [[Endoscopic retrograde cholangiopancreatography]], '''IV'''= Intravenous, '''N'''= Normal, '''AMA'''= Anti mitochondrial antibodies, '''[[LDH]]'''= [[Lactate dehydrogenase]], '''GI'''= Gastrointestinal, '''CXR'''= Chest X ray, '''IgA'''= [[Immunoglobulin A]], '''IgG'''= [[Immunoglobulin G]], '''IgM'''= [[Immunoglobulin M]], '''CT'''= [[Computed tomography]], '''[[PMN]]'''= Polymorphonuclear cells, '''[[ESR]]'''= [[Erythrocyte sedimentation rate]], '''[[CRP]]'''= [[C-reactive protein]], TS= [[Transferrin saturation]], SF= Serum [[Ferritin]], SMA= [[Superior mesenteric artery]], SMV= [[Superior mesenteric vein]], ECG= [[Electrocardiogram]] | |||
<br><br> | |||
'''To review a comprehensive differential diagnosis of diseases presenting with abdominal pain, [[Abdominal pain differential diagnosis#Differential diagnosis of abdominal pain|click here]].''' | |||
The differentials for [[pancreatic cancer]] mainly involve pathologies of the [[pancreas]], [[bile duct]], [[duodenum]], lymphovascular tissue or [[metastasis]] from other sites. It is difficult to differentiate pancreatic cancer from other neoplasms as they all present with non specific constitutional symptoms. Hence, differentiation is primarily based on | ===Differentiating Pancreatic Carcinoma on the basis of involved Organ=== | ||
The differentials for [[pancreatic cancer]] mainly involve pathologies of the [[pancreas]], [[bile duct]], [[duodenum]], lymphovascular tissue or [[metastasis]] from other sites. It is difficult to differentiate pancreatic cancer from other [[neoplasms]] as they all present with non specific constitutional [[symptoms]]. Hence, differentiation is primarily based on anatomic location:<ref name="pmid29029521">{{cite journal |vauthors=He XK, Ding Y, Sun LM |title=Contrast-enhanced endoscopic ultrasound for differential diagnosis of pancreatic cancer: an updated meta-analysis |journal=Oncotarget |volume=8 |issue=39 |pages=66392–66401 |year=2017 |pmid=29029521 |pmc=5630421 |doi=10.18632/oncotarget.18915 |url=}}</ref><ref name="pmid29022085">{{cite journal |vauthors=Steinman J, Zaheer A, Kluger MD, Remotti H, Hecht EM |title=Rare pancreatic tumors |journal=Abdom Radiol (NY) |volume= |issue= |pages= |year=2017 |pmid=29022085 |doi=10.1007/s00261-017-1342-x |url=}}</ref><ref name="pmid28700485">{{cite journal |vauthors=Ran L, Zhao W, Zhao Y, Bu H |title=Value of contrast-enhanced ultrasound in differential diagnosis of solid lesions of pancreas (SLP): A systematic review and a meta-analysis |journal=Medicine (Baltimore) |volume=96 |issue=28 |pages=e7463 |year=2017 |pmid=28700485 |pmc=5515757 |doi=10.1097/MD.0000000000007463 |url=}}</ref><ref name="pmid28216481">{{cite journal |vauthors=Kołodziejczyk E, Wejnarska K, Oracz G |title=Autoimmune pancreatitis in the paediatric population - review of the literature and own experience |journal=Dev Period Med |volume=20 |issue=4 |pages=279–286 |year=2016 |pmid=28216481 |doi= |url=}}</ref><ref name="pmid28197876">{{cite journal |vauthors=Zhu L, Xue HD, Liu W, Wang X, Sui X, Wang Q, Zhang D, Li P, Jin ZY |title=Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics |journal=Radiol Med |volume=122 |issue=5 |pages=337–344 |year=2017 |pmid=28197876 |doi=10.1007/s11547-017-0734-x |url=}}</ref><ref name="pmid28154274">{{cite journal |vauthors=Sano I, Katanuma A, Yane K, Kin T, Nagai K, Yamazaki H, Koga H, Kitagawa K, Yokoyama K, Ikarashi S, Takahashi K, Maguchi H, Omori Y, Shinohara T |title=Pancreatic Metastasis from Rectal Cancer that was Diagnosed by Endoscopic Ultrasonography-guided Fine Needle Aspiration (EUS-FNA) |journal=Intern. Med. |volume=56 |issue=3 |pages=301–305 |year=2017 |pmid=28154274 |pmc=5348454 |doi=10.2169/internalmedicine.56.7213 |url=}}</ref><ref name="pmid27926362">{{cite journal |vauthors=Salaria SN, Shi C |title=Pancreatic Neuroendocrine Tumors |journal=Surg Pathol Clin |volume=9 |issue=4 |pages=595–617 |year=2016 |pmid=27926362 |doi=10.1016/j.path.2016.05.006 |url=}}</ref><ref name="pmid27803081">{{cite journal |vauthors=Kawasaki K, Kawaguchi Y, Suzuki Y, Tanaka N |title=Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase |journal=BMJ Case Rep |volume=2016 |issue= |pages= |year=2016 |pmid=27803081 |doi=10.1136/bcr-2016-214759 |url=}}</ref><ref name="pmid27673319">{{cite journal |vauthors=Nassour I, Choti MA |title=Diagnosis and Treatment of Pancreatic Cystic Neoplasms |journal=JAMA |volume=316 |issue=12 |pages=1326 |year=2016 |pmid=27673319 |doi=10.1001/jama.2016.9130 |url=}}</ref><ref name="pmid28418702">{{cite journal |vauthors=Javadi S, Menias CO, Korivi BR, Shaaban AM, Patnana M, Alhalabi K, Elsayes KM |title=Pancreatic Calcifications and Calcified Pancreatic Masses: Pattern Recognition Approach on CT |journal=AJR Am J Roentgenol |volume=209 |issue=1 |pages=77–87 |year=2017 |pmid=28418702 |doi=10.2214/AJR.17.17862 |url=}}</ref><ref name="pmid27807633">{{cite journal |vauthors=Bergmann F |title=[Pancreatic acinar neoplasms : Comparative molecular characterization] |language=German |journal=Pathologe |volume=37 |issue=Suppl 2 |pages=191–195 |year=2016 |pmid=27807633 |doi=10.1007/s00292-016-0235-z |url=}}</ref><ref name="pmid27232353">{{cite journal |vauthors=Cheng SK, Chuah KL |title=Metastatic Renal Cell Carcinoma to the Pancreas: A Review |journal=Arch. Pathol. Lab. Med. |volume=140 |issue=6 |pages=598–602 |year=2016 |pmid=27232353 |doi=10.5858/arpa.2015-0135-RS |url=}}</ref><ref name="pmid27000276">{{cite journal |vauthors=Haage P, Schwartz CA, Scharwächter C |title=[Ductal adenocarcinoma and unusual differential diagnosis] |language=German |journal=Radiologe |volume=56 |issue=4 |pages=325–37 |year=2016 |pmid=27000276 |doi=10.1007/s00117-016-0090-1 |url=}}</ref><ref name="pmid26777740">{{cite journal |vauthors=Scialpi M, Reginelli A, D'Andrea A, Gravante S, Falcone G, Baccari P, Manganaro L, Palumbo B, Cappabianca S |title=Pancreatic tumors imaging: An update |journal=Int J Surg |volume=28 Suppl 1 |issue= |pages=S142–55 |year=2016 |pmid=26777740 |doi=10.1016/j.ijsu.2015.12.053 |url=}}</ref><ref name="pmid25799073">{{cite journal |vauthors=Senosiain Lalastra C, Foruny Olcina JR |title=[Autoimmune pancreatitis] |language=Spanish; Castilian |journal=Gastroenterol Hepatol |volume=38 |issue=9 |pages=549–55 |year=2015 |pmid=25799073 |doi=10.1016/j.gastrohep.2015.01.006 |url=}}</ref><ref name="pmid25638877">{{cite journal |vauthors=Barbier L, Delpero JR |title=[Pancreatic tumours] |language=French |journal=Rev Prat |volume=64 |issue=9 |pages=1307–12 |year=2014 |pmid=25638877 |doi= |url=}}</ref><ref name="pmid25288201">{{cite journal |vauthors=Díte P, Uvírová M, Bojková M, Novotný I, Dvorácková J, Kianicka B, Nechutová H, Dovrtelová L, Floreánová K, Martínek A |title=Differentiating autoimmune pancreatitis from pancreatic cancer |journal=Minerva Gastroenterol Dietol |volume=60 |issue=4 |pages=247–53 |year=2014 |pmid=25288201 |doi= |url=}}</ref><ref name="pmid25063236">{{cite journal |vauthors=Lalwani N, Mannelli L, Ganeshan DM, Shanbhogue AK, Dighe MK, Tiwari HA, Maximin S, Monti S, Ragucci M, Prasad SR |title=Uncommon pancreatic tumors and pseudotumors |journal=Abdom Imaging |volume=40 |issue=1 |pages=167–80 |year=2015 |pmid=25063236 |doi=10.1007/s00261-014-0189-7 |url=}}</ref><ref name="pmid24572485">{{cite journal |vauthors=Dite P, Nechutova H, Uvirova M, Dvorackova J, Kianicka B, Martinek A |title=Autoimmune pancreatitis |journal=Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub |volume=158 |issue=1 |pages=17–22 |year=2014 |pmid=24572485 |doi=10.5507/bp.2013.094 |url=}}</ref><ref name="pmid24242859">{{cite journal |vauthors=Mastoraki A, Tzortzopoulou A, Tsela S, Danias N, Sakorafas G, Smyrniotis V, Arkadopoulos N |title=Hereditary pancreatitis: dilemmas in differential diagnosis and therapeutic approach |journal=J Gastrointest Cancer |volume=45 |issue=1 |pages=22–6 |year=2014 |pmid=24242859 |doi=10.1007/s12029-013-9559-6 |url=}}</ref><ref name="pmid24193862">{{cite journal |vauthors=Beyer G, Menzel J, Krüger PC, Ribback S, Lerch MM, Mayerle J |title=[Autoimmune pancreatitis] |language=German |journal=Dtsch. Med. Wochenschr. |volume=138 |issue=46 |pages=2359–70; quiz 2371–4 |year=2013 |pmid=24193862 |doi=10.1055/s-0033-1349475 |url=}}</ref><ref name="pmid24060833">{{cite journal |vauthors=Al-Hawary MM, Kaza RK, Azar SF, Ruma JA, Francis IR |title=Mimics of pancreatic ductal adenocarcinoma |journal=Cancer Imaging |volume=13 |issue=3 |pages=342–9 |year=2013 |pmid=24060833 |pmc=3800430 |doi=10.1102/1470-7330.2013.9012 |url=}}</ref><ref name="pmid23918083">{{cite journal |vauthors=Bednar F, Scheiman JM, McKenna BJ, Simeone DM |title=Breast cancer metastases to the pancreas |journal=J. Gastrointest. Surg. |volume=17 |issue=10 |pages=1826–31 |year=2013 |pmid=23918083 |doi=10.1007/s11605-013-2291-5 |url=}}</ref><ref name="pmid23852141">{{cite journal |vauthors=DiMagno MJ, DiMagno EP |title=Chronic pancreatitis |journal=Curr. Opin. Gastroenterol. |volume=29 |issue=5 |pages=531–6 |year=2013 |pmid=23852141 |pmc=4387887 |doi=10.1097/MOG.0b013e3283639370 |url=}}</ref><ref name="pmid28831506">{{cite journal |vauthors=Berger AW, Seufferlein T, Kleger A |title=[Cystic pancreatic tumors: diagnostics and new biomarkers] |language=German |journal=Chirurg |volume=88 |issue=11 |pages=905–912 |year=2017 |pmid=28831506 |doi=10.1007/s00104-017-0493-1 |url=}}</ref><ref name="pmid27840080">{{cite journal |vauthors=Nougaret S, Mannelli L, Pierredon MA, Schembri V, Guiu B |title=Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas |journal=Diagn Interv Imaging |volume=97 |issue=12 |pages=1275–1285 |year=2016 |pmid=27840080 |doi=10.1016/j.diii.2016.08.017 |url=}}</ref><ref name="pmid28858107">{{cite journal |vauthors=Xu MM, Yin S, Siddiqui AA, Salem RR, Schrope B, Sethi A, Poneros JM, Gress FG, Genkinger JM, Do C, Brooks CA, Chabot JA, Kluger MD, Kowalski T, Loren DE, Aslanian H, Farrell JJ, Gonda TA |title=Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms |journal=Medicine (Baltimore) |volume=96 |issue=35 |pages=e7900 |year=2017 |pmid=28858107 |pmc=5585501 |doi=10.1097/MD.0000000000007900 |url=}}</ref><ref name="pmid26818541">{{cite journal |vauthors=Dong J, Cong L, Zhang TP, Zhao YP |title=Pancreatic metastasis of renal cell carcinoma |journal=HBPD INT |volume=15 |issue=1 |pages=30–8 |year=2016 |pmid=26818541 |doi= |url=}}</ref> | |||
{| class="wikitable" | {| class="wikitable" | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Origin | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Origin | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Diagnostic study of choice | ||
|- | |- | ||
| style="background:#DCDCDC; + " | '''Pancreas''' | | style="background:#DCDCDC; + " | '''[[Pancreas]]''' | ||
| | | | ||
* [[Chronic pancreatitis]] | * [[Chronic pancreatitis]] | ||
Line 687: | Line 475: | ||
* [[Imaging]]: Non-contrast helical [[Computed tomography|CT]] | * [[Imaging]]: Non-contrast helical [[Computed tomography|CT]] | ||
* [[Biopsy]] findings | * [[Biopsy]] findings | ||
* Serum [[IgG4-related systemic disease|IgG4]] levels for autoimmune pancreatitis | * Serum [[IgG4-related systemic disease|IgG4]] levels for [[autoimmune]] [[pancreatitis]] | ||
* For pancreatic [[Neuroendocrine tumors|NETs]]: | * For [[pancreatic]] [[Neuroendocrine tumors|NETs]]: | ||
** [[Gastrin]] levels | ** [[Gastrin]] levels | ||
** [[Somatostatin]] levels | ** [[Somatostatin]] levels | ||
** [[Insulin]] levels | ** [[Insulin]] levels | ||
** Serum electrolytes | ** Serum [[Electrolyte|electrolytes]] | ||
|- | |- | ||
| style="background:#DCDCDC; + " | '''Bile duct''' | | style="background:#DCDCDC; + " | '''Bile duct''' | ||
Line 711: | Line 499: | ||
* [[Biopsy]] findings | * [[Biopsy]] findings | ||
|- | |- | ||
| style="background:#DCDCDC; + " | '''Duodenum''' | | style="background:#DCDCDC; + " | '''[[Duodenum]]''' | ||
| | | | ||
* Ampullary cancer | * [[Ampulla|Ampullary cancer]] | ||
* [[Duodenum|Duodenal]] cancer | * [[Duodenum|Duodenal]] cancer | ||
| | | | ||
Line 737: | Line 525: | ||
* [[Biopsy]] for [[lymphoma]] | * [[Biopsy]] for [[lymphoma]] | ||
|- | |- | ||
| style="background:#DCDCDC; + " | '''Metastasis''' | | style="background:#DCDCDC; + " | '''[[Metastasis]]''' | ||
| | | | ||
* [[Skin]]([[Melanoma]]) | * [[Skin]]([[Melanoma]]) | ||
Line 757: | Line 545: | ||
** [[Melanoma]]: [[S100B|S100]] | ** [[Melanoma]]: [[S100B|S100]] | ||
|} | |} | ||
==References== | ==References== | ||
Line 764: | Line 551: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Surgery]] | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] |
Latest revision as of 20:25, 13 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]
Overview
Pancreatic cancer must be distinguished from other pancreatobiliary pathologies that cause abdominal pain and jaundice such as acute suppurative cholangitis, acute cholecystitis, cholelithiasis, chronic pancreatitis, primary biliary cirrhosis and primary sclerosing cholangitis. Pancreatic cancer must also be differentiated from other pancreatic pathologies such as autoimmune pancreatitis, pancreatic pseudocyst, and neuroendocrine tumors of the pancreas. Pathologies of the bile duct and duodenum such as Choledocholithiasis, gallstones (cholelithiasis), choledochal cysts, Cholangiocarcinoma, Bile duct strictures and ampullary cancer should be differentiated from pancreatic cancer based on imaging and biopsy findings. Metastasis from different sites and vascular causes such as abdominal aortic aneurysms may also mimic pancreatic cancer.
Differentiating Pancreatic Cancer from other Diseases
Pancreatic cancer may also be distinguished from other causes of abdominal pain and jaundice as depicted in the table below:
|
Differentials based on weight loss, nausea, vomiting, diarrhea, fatigue and abdominal pain
Pancreatic carcinoma should be differentiated from other diseases presenting with weight loss, nausea, vomiting, diarrhea, fatigue and abdominal pain. The differentials include the following:
Disease | Clinical manifestations | Diagnosis | Comments | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | |||||||||||||||
Abdominal Pain | Fever | Rigors and chills | Nausea or vomiting | Jaundice | Constipation | Diarrhea | Weight loss | GI bleeding | Hypo-
tension |
Guarding | Rebound Tenderness | Bowel sounds | Lab Findings | Imaging | ||
Chronic pancreatitis | Epigastric | − | − | ± | ± | − | + | + | − | − | − | − | N | CT scan
|
| |
Pancreatic carcinoma | Epigastric | − | − | + | + | − | + | + | − | − | − | − | N |
Skin manifestations may include: | ||
Dumping syndrome | Lower and then diffuse | − | − | + | − | − | + | + | − | + | − | − | Hyperactive |
|
|
Abbreviations:
RUQ= Right upper quadrant of the abdomen, LUQ= Left upper quadrant, LLQ= Left lower quadrant, RLQ= Right lower quadrant, LFT= Liver function test, SIRS= Systemic inflammatory response syndrome, ERCP= Endoscopic retrograde cholangiopancreatography, IV= Intravenous, N= Normal, AMA= Anti mitochondrial antibodies, LDH= Lactate dehydrogenase, GI= Gastrointestinal, CXR= Chest X ray, IgA= Immunoglobulin A, IgG= Immunoglobulin G, IgM= Immunoglobulin M, CT= Computed tomography, PMN= Polymorphonuclear cells, ESR= Erythrocyte sedimentation rate, CRP= C-reactive protein, TS= Transferrin saturation, SF= Serum Ferritin, SMA= Superior mesenteric artery, SMV= Superior mesenteric vein, ECG= Electrocardiogram
To review a comprehensive differential diagnosis of diseases presenting with abdominal pain, click here.
Differentiating Pancreatic Carcinoma on the basis of involved Organ
The differentials for pancreatic cancer mainly involve pathologies of the pancreas, bile duct, duodenum, lymphovascular tissue or metastasis from other sites. It is difficult to differentiate pancreatic cancer from other neoplasms as they all present with non specific constitutional symptoms. Hence, differentiation is primarily based on anatomic location:[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28]
Origin | Disease | Diagnostic study of choice |
---|---|---|
Pancreas |
| |
Bile duct | ||
Duodenum |
|
|
Lymphovascular
tissue |
| |
Metastasis |
References
- ↑ He XK, Ding Y, Sun LM (2017). "Contrast-enhanced endoscopic ultrasound for differential diagnosis of pancreatic cancer: an updated meta-analysis". Oncotarget. 8 (39): 66392–66401. doi:10.18632/oncotarget.18915. PMC 5630421. PMID 29029521.
- ↑ Steinman J, Zaheer A, Kluger MD, Remotti H, Hecht EM (2017). "Rare pancreatic tumors". Abdom Radiol (NY). doi:10.1007/s00261-017-1342-x. PMID 29022085.
- ↑ Ran L, Zhao W, Zhao Y, Bu H (2017). "Value of contrast-enhanced ultrasound in differential diagnosis of solid lesions of pancreas (SLP): A systematic review and a meta-analysis". Medicine (Baltimore). 96 (28): e7463. doi:10.1097/MD.0000000000007463. PMC 5515757. PMID 28700485.
- ↑ Kołodziejczyk E, Wejnarska K, Oracz G (2016). "Autoimmune pancreatitis in the paediatric population - review of the literature and own experience". Dev Period Med. 20 (4): 279–286. PMID 28216481.
- ↑ Zhu L, Xue HD, Liu W, Wang X, Sui X, Wang Q, Zhang D, Li P, Jin ZY (2017). "Enhancing pancreatic mass with normal serum CA19-9: key MDCT features to characterize pancreatic neuroendocrine tumours from its mimics". Radiol Med. 122 (5): 337–344. doi:10.1007/s11547-017-0734-x. PMID 28197876.
- ↑ Sano I, Katanuma A, Yane K, Kin T, Nagai K, Yamazaki H, Koga H, Kitagawa K, Yokoyama K, Ikarashi S, Takahashi K, Maguchi H, Omori Y, Shinohara T (2017). "Pancreatic Metastasis from Rectal Cancer that was Diagnosed by Endoscopic Ultrasonography-guided Fine Needle Aspiration (EUS-FNA)". Intern. Med. 56 (3): 301–305. doi:10.2169/internalmedicine.56.7213. PMC 5348454. PMID 28154274.
- ↑ Salaria SN, Shi C (2016). "Pancreatic Neuroendocrine Tumors". Surg Pathol Clin. 9 (4): 595–617. doi:10.1016/j.path.2016.05.006. PMID 27926362.
- ↑ Kawasaki K, Kawaguchi Y, Suzuki Y, Tanaka N (2016). "Renal neuroendocrine tumour and synchronous pancreas metastasis: histopathological diagnosis using prostatic acid phosphatase". BMJ Case Rep. 2016. doi:10.1136/bcr-2016-214759. PMID 27803081.
- ↑ Nassour I, Choti MA (2016). "Diagnosis and Treatment of Pancreatic Cystic Neoplasms". JAMA. 316 (12): 1326. doi:10.1001/jama.2016.9130. PMID 27673319.
- ↑ Javadi S, Menias CO, Korivi BR, Shaaban AM, Patnana M, Alhalabi K, Elsayes KM (2017). "Pancreatic Calcifications and Calcified Pancreatic Masses: Pattern Recognition Approach on CT". AJR Am J Roentgenol. 209 (1): 77–87. doi:10.2214/AJR.17.17862. PMID 28418702.
- ↑ Bergmann F (2016). "[Pancreatic acinar neoplasms : Comparative molecular characterization]". Pathologe (in German). 37 (Suppl 2): 191–195. doi:10.1007/s00292-016-0235-z. PMID 27807633.
- ↑ Cheng SK, Chuah KL (2016). "Metastatic Renal Cell Carcinoma to the Pancreas: A Review". Arch. Pathol. Lab. Med. 140 (6): 598–602. doi:10.5858/arpa.2015-0135-RS. PMID 27232353.
- ↑ Haage P, Schwartz CA, Scharwächter C (2016). "[Ductal adenocarcinoma and unusual differential diagnosis]". Radiologe (in German). 56 (4): 325–37. doi:10.1007/s00117-016-0090-1. PMID 27000276.
- ↑ Scialpi M, Reginelli A, D'Andrea A, Gravante S, Falcone G, Baccari P, Manganaro L, Palumbo B, Cappabianca S (2016). "Pancreatic tumors imaging: An update". Int J Surg. 28 Suppl 1: S142–55. doi:10.1016/j.ijsu.2015.12.053. PMID 26777740.
- ↑ Senosiain Lalastra C, Foruny Olcina JR (2015). "[Autoimmune pancreatitis]". Gastroenterol Hepatol (in Spanish; Castilian). 38 (9): 549–55. doi:10.1016/j.gastrohep.2015.01.006. PMID 25799073.
- ↑ Barbier L, Delpero JR (2014). "[Pancreatic tumours]". Rev Prat (in French). 64 (9): 1307–12. PMID 25638877.
- ↑ Díte P, Uvírová M, Bojková M, Novotný I, Dvorácková J, Kianicka B, Nechutová H, Dovrtelová L, Floreánová K, Martínek A (2014). "Differentiating autoimmune pancreatitis from pancreatic cancer". Minerva Gastroenterol Dietol. 60 (4): 247–53. PMID 25288201.
- ↑ Lalwani N, Mannelli L, Ganeshan DM, Shanbhogue AK, Dighe MK, Tiwari HA, Maximin S, Monti S, Ragucci M, Prasad SR (2015). "Uncommon pancreatic tumors and pseudotumors". Abdom Imaging. 40 (1): 167–80. doi:10.1007/s00261-014-0189-7. PMID 25063236.
- ↑ Dite P, Nechutova H, Uvirova M, Dvorackova J, Kianicka B, Martinek A (2014). "Autoimmune pancreatitis". Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 158 (1): 17–22. doi:10.5507/bp.2013.094. PMID 24572485.
- ↑ Mastoraki A, Tzortzopoulou A, Tsela S, Danias N, Sakorafas G, Smyrniotis V, Arkadopoulos N (2014). "Hereditary pancreatitis: dilemmas in differential diagnosis and therapeutic approach". J Gastrointest Cancer. 45 (1): 22–6. doi:10.1007/s12029-013-9559-6. PMID 24242859.
- ↑ Beyer G, Menzel J, Krüger PC, Ribback S, Lerch MM, Mayerle J (2013). "[Autoimmune pancreatitis]". Dtsch. Med. Wochenschr. (in German). 138 (46): 2359–70, quiz 2371–4. doi:10.1055/s-0033-1349475. PMID 24193862.
- ↑ Al-Hawary MM, Kaza RK, Azar SF, Ruma JA, Francis IR (2013). "Mimics of pancreatic ductal adenocarcinoma". Cancer Imaging. 13 (3): 342–9. doi:10.1102/1470-7330.2013.9012. PMC 3800430. PMID 24060833.
- ↑ Bednar F, Scheiman JM, McKenna BJ, Simeone DM (2013). "Breast cancer metastases to the pancreas". J. Gastrointest. Surg. 17 (10): 1826–31. doi:10.1007/s11605-013-2291-5. PMID 23918083.
- ↑ DiMagno MJ, DiMagno EP (2013). "Chronic pancreatitis". Curr. Opin. Gastroenterol. 29 (5): 531–6. doi:10.1097/MOG.0b013e3283639370. PMC 4387887. PMID 23852141.
- ↑ Berger AW, Seufferlein T, Kleger A (2017). "[Cystic pancreatic tumors: diagnostics and new biomarkers]". Chirurg (in German). 88 (11): 905–912. doi:10.1007/s00104-017-0493-1. PMID 28831506.
- ↑ Nougaret S, Mannelli L, Pierredon MA, Schembri V, Guiu B (2016). "Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas". Diagn Interv Imaging. 97 (12): 1275–1285. doi:10.1016/j.diii.2016.08.017. PMID 27840080.
- ↑ Xu MM, Yin S, Siddiqui AA, Salem RR, Schrope B, Sethi A, Poneros JM, Gress FG, Genkinger JM, Do C, Brooks CA, Chabot JA, Kluger MD, Kowalski T, Loren DE, Aslanian H, Farrell JJ, Gonda TA (2017). "Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms". Medicine (Baltimore). 96 (35): e7900. doi:10.1097/MD.0000000000007900. PMC 5585501. PMID 28858107.
- ↑ Dong J, Cong L, Zhang TP, Zhao YP (2016). "Pancreatic metastasis of renal cell carcinoma". HBPD INT. 15 (1): 30–8. PMID 26818541.